InvestorsHub Logo
Followers 0
Posts 70
Boards Moderated 0
Alias Born 03/02/2020

Re: lucky, mydog post# 3775

Monday, 06/01/2020 6:33:09 PM

Monday, June 01, 2020 6:33:09 PM

Post# of 4199
As I understand it fast track is FDA not EPA.
The MSDA safety data sheet says experimental mostly.
Did this company bother to look?
Needs additional argument support in my opinion.

[Snip]
"Magic with EPA call included company background, company products, available
information about povidone-iodine, the reregistration process for povidone-iodine, likely
registration process for Halo, EPA considerations to fast-track COVID-19 products,
likely timelines, EPA process for package review, and fees. This breadth of topics is a
one and one-half hour substantive call.
Nano Magic came into the call understanding that using povidone-iodine in Halo
may enable access to a fast track process available for products that could be used against
COVID-19. The company learned about limitations to the process, given the EPA’s
23
obligation to assess the safety of products, even if data about COVID-19 efficacy existed.
The conversation ended with Nano Magic informing the EPA that the company would
revisit – not abandon – its short-term and long-term product to market strategy."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NMGX News